je.st
news
UPDATE 2-J&J in $1 bln deal to bolster prostate-cancer focus
2013-06-18 14:11:28| Food - Topix.net
Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
Tags: update
focus
deal
bolster
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||